Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CEL | P19835 | 2/20 | 0.38 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.38 |
| ▸ | KMO | O15229 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | CASP3 | P42574 | 1/20 | 0.35 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.35 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.35 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.34 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.34 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.34 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.33 |
| ▸ | PTPRC | P08575 | 1/20 | 0.33 |
| ▸ | PTPRF | P10586 | 1/20 | 0.33 |
| ▸ | CDC25B | P30305 | 1/20 | 0.33 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.32 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.31 |
| ▸ | HTR1A | P08908 | 1/20 | 0.31 |
| ▸ | DRD2 | P14416 | 1/20 | 0.31 |
| ▸ | HTR2A | P28223 | 1/20 | 0.31 |
| ▸ | HTR7 | P34969 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21777712 | 0.97 | CEL (0.36) | CELCYP11B2KMOPOLBCASP3 | |
| SCHEMBL17710524 | 0.92 | CEL (0.32) | CELCYP11B2KMOHDAC4HDAC2 | |
| SCHEMBL16752251 | 0.87 | AKR1C3 (0.31) | — | |
| SCHEMBL1776322 | 0.85 | CEL (0.33) | CELCYP11B2KMOPOLBCASP3 | |
| SCHEMBL4886658 | 0.82 | CEL (0.32) | CELKMOCASP3SENP7SENP6 | |
| SCHEMBL1778508 | 0.82 | CEL (0.32) | CELCYP11B2KMO | |
| SCHEMBL1776833 | 0.82 | PTPN1 (0.34) | CELCYP11B2KMOPTPN1PTPRC | |
| SCHEMBL6285498 | 0.80 | CASP3 (0.41) | CELKMOPOLBCASP3SENP7 | |
| SCHEMBL1777508 | 0.80 | HTR1A (0.31) | CELCYP11B2KMOHTR1ADRD2 | |
| SCHEMBL7949502 | 0.78 | POLB (0.30) | POLBCASP3SENP7SENP6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 173 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240216900-A1 | SABRE CATALYSTS CONTAINING FLUORINATED CARBON CHAINS FOR DELIVERY OF METAL-FREE MRI CONTRAST AGENTS | THE U.S.A., AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2024-07-04 | — | — | US | claimed |
| CN-117551134-A | Complex and preparation method and application thereof | 南京佳诺霖光电科技有限公司 | 2024-02-13 | — | — | CN | claimed |
| WO-2024022413-A1 | DIVALENT METAL COMPLEX, PREPARATION METHOD THEREFOR AND USE THEREOF, AND ORGANIC OPTOELECTRONIC DEVICE | 中国石油化工股份有限公司 | 2024-02-01 | — | — | WO | claimed |
| CN-117466944-A | Divalent metal complex, preparation method and application thereof, and organic photoelectric device | 中国石油化工股份有限公司 | 2024-01-30 | — | — | CN | claimed |
| WO-2023196594-A2 | SABRE CATALYSTS CONTAINING FLUORINATED CARBON CHAINS FOR DELIVERY OF METAL-FREE MRI CONTRAST AGENTS | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2023-10-12 | — | — | WO | claimed |
| CN-116574136-A | Bivalent platinum complex and preparation method and application thereof | 南京佳诺霖光电科技有限公司 | 2023-08-11 | — | — | CN | claimed |
| CN-115991724-A | Blue phosphorescence bivalent platinum complex, preparation method and application thereof, and organic photoelectric device | 中国石油化工股份有限公司 | 2023-04-21 | — | — | CN | claimed |
| CN-115991725-A | Green phosphorescence bivalent platinum complex, preparation method and application thereof, and organic photoelectric device | 中国石油化工股份有限公司 | 2023-04-21 | — | — | CN | claimed |
| CN-115991722-A | Yellow-green phosphorescence bivalent platinum complex, preparation method and application thereof, and organic photoelectric device | 中国石油化工股份有限公司 | 2023-04-21 | — | — | CN | claimed |
| CN-115700254-A | Bivalent platinum complex and preparation method and application thereof | 南京工业大学 | 2023-02-07 | — | — | CN | claimed |
| US-20190177449-A1 | Quinolinyldiamido Transition Metal Complexes, Production and Use Thereof | EXXONMOBIL CHEMICAL PATENTS INC. | 2019-06-13 | — | — | US | claimed |
| EP-3478694-A1 | QUINOLINYLDIAMIDO TRANSITION METAL COMPLEXES, PRODUCTION AND USE THEREOF | ExxonMobil Chemical Patents Inc. (US) | 2019-05-08 | — | — | EP | claimed |
| US-10208140-B2 | Quinolinyldiamido transition metal complexes, production and use thereof | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2019-02-19 | — | — | US | claimed |
| US-20180319907-A1 | Long Chain Branched Polypropylene Via Polymerization with Aluminum Vinyl Transfer Agent | EXXONMOBIL CHEMICAL PATENTS INC. | 2018-11-08 | — | — | US | claimed |
| WO-2018160276-A1 | POLYMERS PRODUCED VIA USE OF QUINOLINYLDIAMIDO TRANSITION METAL COMPLEXES AND VINYL TRANSFER AGENTS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2018-09-07 | — | — | WO | claimed |
| US-20180134816-A1 | Polymers Produced via Use of Quinolinyldiamido Transition Metal Complexes and Vinyl Transfer Agents | EXXONMOBIL CHEMICAL PATENTS INC. | 2018-05-17 | — | — | US | claimed |
| US-20180002352-A1 | Quinolinyldiamido Transition Metal Complexes, Production and Use Thereof | EXXONMOBIL CHEMICAL PATENTS INC. | 2018-01-04 | — | — | US | claimed |
| WO-2018005201-A1 | QUINOLINYLDIAMIDO TRANSITION METAL COMPLEXES, PRODUCTION AND USE THEREOF | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2018-01-04 | — | — | WO | claimed |
| US-5530162-A | Process for the hydrogenation of aryl phosphines and products obtained therefrom | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1996-06-25 | — | — | US | claimed |
| WO-1993021192-A1 | PROCESS FOR THE HYDROGENATION OF ARYL PHOSPHINES AND PRODUCTS OBTTAINED THEREFROM | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1993-10-28 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240216900-A1 | SABRE CATALYSTS CONTAINING FLUORINATED CARBON CHAINS FOR DELIVERY OF METAL-FREE MRI CONTRAST AGENTS | FABP7, FFAR1, FABP1 | CEL 362/4885CYP11B2 1280/4885KMO 1409/4885 |
| US-10208140-B2 | Quinolinyldiamido transition metal complexes, production and use thereof | PARN, PARG, PICALM | CEL 4717/4885CYP11B2 3657/4885KMO 344/4885 |
| US-20180002352-A1 | Quinolinyldiamido Transition Metal Complexes, Production and Use Thereof | PARN, PARG, PICALM | CEL 4717/4885CYP11B2 3657/4885KMO 344/4885 |
| US-20190177449-A1 | Quinolinyldiamido Transition Metal Complexes, Production and Use Thereof | PARN, PARG, PICALM | CEL 4717/4885CYP11B2 3657/4885KMO 344/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.